Testing dapansutrile for type 2 diabetes and related problems
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests if a drug called dapansutrile can help control blood sugar and reduce inflammation in people with type 2 diabetes. It may also help prevent or manage diabetes-related complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes for at least 3 months.
- Your average blood sugar (HbA1c) is between 7.7% and 11.0% at screening.
- You have a body mass index (BMI) between 25 and 40.
- You have a certain level of inflammation (hsCRP 1.5 mg/L or higher).
- You have not had a heart attack or heart surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational injectable medicine (IN-B00009) to see how well it controls blood sugar in adults with type 2 diabetes that is not well managed by diet and exercise alone. If you qualify, you may receive the study drug and will be monitored closely to see if it helps lower your blood sugar safely.
This trial tests an experimental pill called DA-302168S to see if it helps lower blood sugar in people with type 2 diabetes. It is for patients who are already managing their diabetes with metformin or lifestyle changes, and it focuses on safety and effectiveness over about 6 months.
This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.
This early-phase study tests a new investigational drug called PATAS, first in healthy volunteers and then in people with type 2 diabetes, to see how safe it is and how the body handles it. It may help future treatments for diabetes, but it does not prove effectiveness yet.
Hear when a new Diabetes Mellitus, Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.